Kelvin Teo, MBBS, PhD, senior consultant, Advanced Eye Clinic & Surgery, adjunct associate professor, Duke NUS Eye ACP, Singapore, presents real-world data showing that a single 8-mg dose…
Andrew Chang, MBBS, PhD, consultant ophthalmologist and head of Ophthalmology, Sydney Eye Hospital, Australia, shares real-world experience using 8-mg intravitreal aflibercept for neovascular age-related macular degeneration and reports…
NEW YORK (Reuters Health) – While oxybutynin is often used prophylactically to reduce irritative urinary symptoms related to intravesical bacillus Calmette-Guerin (BCG) therapy for bladder cancer, it actually…
Philip Low, PhD, Founder, Chairman & CEO, NeuroVigil, talks about the evolution of highly sensitive brain sensors. Read more on the iBrain. Filmed at FutureMed, in February, 2012,…
Throughout the year, but especially during the winter months, outbreaks of norovirus commonly referred to as the “stomach flu” can occur. Symptoms may include abdominal cramps, vomiting, and…
NEW YORK (Reuters Health) – Complete bladder neck preservation during radical prostatectomy improves the rate of urinary continence subsequently, a German team reports. Furthermore, the strategy is associated…
NEW YORK (Reuters Health) – Intravesical bacille Calmette-Guérin (BCG) therapy for bladder cancer is associated with eradication of uropathogens in patients not taking antibiotics, according to a new…
Ajay Verma, MD, PhD, VP, Neurodegeneration & Translational Neurology, Biogen Idec, suggests that we carry a biologic blueprint for death that may include “grim reaper” mechanisms. Filmed at FutureMed,…
Randy Scott, PhD, Executive Chairman, Genomic Health, talks about advances in genome-based testing and understanding of cancer. Filmed at FutureMed, in February, 2012, at Singularity University.
Amir Belson, MD, CTO, Neoguide Systems, discusses his invention of the Neoguide colonoscope. Filmed at FutureMed, in February, 2012, at Singularity University.
